Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Eisai files for approval of Alzheimer's drug in Europe

Japanese drugmaker Eisai said on Tuesday (January 10) it had submitted a marketing application to the European health regulator for review of its Alzheimer's drug lecanemab, which was recently granted accelerated approval in the United States.

The drug, developed in partnership with Biogen, is an antibody that has been shown to remove sticky deposits of a protein called amyloid beta from the brains of those in the early stages of the mind-wasting disease. Nearly all previous experimental drugs using the same approach have failed.


The company's application to the European Medicines Agency is based on results from a late-stage study in which the drug was shown to slow down the rate of cognitive decline in patients with early Alzheimer's by 27 per cent, compared with a placebo.

Eisai also reiterated its plans to apply for marketing authorization of the drug in Japan by the end of its business year on March 31.

The company also applied for full approval of the drug with the U.S. Food and Drug Administration last week as a treatment for patients in the earliest stages of the neurodegenerative disease.

More For You

Weight-loss drugs Wegovy or Zepbound

Studies have shown that most patients who quit their GLP-1 drugs usually regain most of the weight.

Pic credit: iStock

New data show most US patients now stay on Wegovy, Zepbound after a year

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of US pharmacy claims.

That level of persistence is higher than what prior analyses have shown, suggesting that more patients might be staying on the popular GLP-1 drugs for obesity as product shortages ease, insurance coverage expands and doctors manage side effects better, health experts say.

Keep ReadingShow less
A pregnant woman being vaccinated

Maternal vaccine uptake hits 73% in UK

Getty Images

Pregnant women’s whooping cough vaccination rates on the rise

Key Summary

  • Maternal whooping cough vaccination rates have risen to 73 per cent after a major outbreak affected over 3,000 people
  • The jab protects babies from a potentially fatal disease that caused 11 infant deaths in England last year
  • UKHSA urges all pregnant women to get vaccinated from 20 weeks to safeguard their newborns

The UK Health Security Agency (UKHSA) recently declared that the number of pregnant women coming forward for the whooping cough vaccine IS rising significantly.

Keep ReadingShow less
Health services come under strain during winters

Community Pharmacy Northern Ireland has been involved in the Department of Health’s winter preparedness planning.

iStock

CPNI advocates whole-system approach to beat winter pressures

Key Summary

  • CPNI chief Gerard Greene met a group of MLAs to discuss measures to avert the health service crisis seen in previous winters
  • Community pharmacies will be involved in the Covid and winter flu vaccination service from the autumn
  • The vaccination drive will help avert flu outbreaks during winter and ease pressure on hospital services

Community Pharmacy Northern Ireland (CPNI) recently held a discussion with local political leaders about the need for a whole service, whole community approach to tackling this winter’s health pressures.

Keep ReadingShow less
GPhC, Pharmacist Support signed a memorandum of understanding (MoU)

The two organisations will collaborate to promote the well-being of pharmacists.

iStock

GPhC, Pharmacist Support join forces for well-being of pharmacy professionals

Key Summary

  • General Pharmaceutical Council and Pharmacist Support will advise each other on broad areas of concern
  • The two organisations will use joint resources to the benefit of both
  • They will work towards the well-being of pharmacy professionals, as it impacts their ability to keep patients safe

The General Pharmaceutical Council (GPhC) and Pharmacist Support have signed a memorandum of understanding (MoU) to support the well-being of pharmacy professionals.

Keep ReadingShow less
Pharmacist Mahendra Patel awarded Honorary Fellowship by Royal College of General Practitioners

Pharmacist Mahendra Patel awarded Honorary Fellowship by Royal College of General Practitioners

Pharmacist Mahendra Patel awarded Honorary Fellowship by Royal College of General Practitioners

Professor Mahendra Patel hopes community pharmacies and GPs can “join hands to improve health outcomes” after he became the first pharmacist in England to be awarded an Honorary Fellowship by the Royal College of General Practitioners (RCGP).

Patel’s distinguished career in pharmacy has seen him make an incredible contribution to the sector in his roles in community pharmacy, health policy, professional leadership, and inclusive research nationally and internationally.

Keep ReadingShow less